Skip to main content
Toggle navigation
Search
Home
Back
Favorite
0
Like
Facebook
Tweet
Print
SESSION 2: AN APPROVAL DEBATE - ADJUVANT ABEMACICLIB
DEBATE: Adjuvant Abemaciclib Approval: Should Be Broadened
Wednesday, April 27, 2022
11:55 AM – 12:10 PM
Debate Speaker(s)
Sara M. Tolaney, MD, MPH
Dana-Farber Cancer Institute; Harvard Medical School
Boston, Massachusetts